Therma Bright Expects Rapid Antigen Saliva Test Study To Conclude This Month
Therma Bright (TSXV: THRM) this morning provided a brief update to investors on the status of its clinical study. The
Read moreTherma Bright (TSXV: THRM) this morning provided a brief update to investors on the status of its clinical study. The
Read moreTherma Bright (TSXV: THRM) has taken back control of the research and development, regulatory, manufacturing and commercialization of its saliva-based
Read moreTherma Bright Inc (TSXV: THRM) this afternoon halted its equity from trading for the dying minutes of the days session
Read moreTherma Bright Inc (TSXV: THRM) this morning announced that its development partner for its COVID-19 rapid saliva-based screening test has
Read more